Sialyllactose suppresses angiogenesis by inhibiting VEGFR-2 activation, and tumor progression

Chung, TW; Kim, EY; Kim, SJ; Choi, HJ; Jang, SB; Kim, KJ; Ha, SH; Abekura, F; Kwak, CH; Kim, CH; Ha, KT

Ha, KT (reprint author), Pusan Natl Univ, Hlth Aging Korean Med Res Ctr, Sch Korean Med, Yangsan 50612, Gyeongsangnam D, South Korea.; Ha, KT (reprint author), Pusan Natl Univ, Grad Training Program Korean Med Hlth Aging, Yangsan 50612, Gyeongsangnam D, S

ONCOTARGET, 2017; 8 (35): 58152